![Pirkko Sulila Tamsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pirkko Sulila Tamsen
Directeur Général chez Arandi Innovation AB
Postes actifs de Pirkko Sulila Tamsen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Arandi Innovation AB | Directeur Général | 01/08/2008 | - |
Président | 01/08/2008 | - | |
Oerebro Universitet Uppdrag AB | Directeur/Membre du Conseil | - | - |
Oerebro Universitet Enterprise AB
![]() Oerebro Universitet Enterprise AB Miscellaneous Commercial ServicesCommercial Services Oerebro Universitet Enterprise AB is a Swedish company that engages in other scientific and technical research & development. The private company is based in Örebro, Sweden. | Directeur/Membre du Conseil | - | - |
Hepapredict AB | Directeur/Membre du Conseil | - | - |
C26 Bioscience AB | Directeur/Membre du Conseil | - | - |
Arandi Development AB
![]() Arandi Development AB Pharmaceuticals: MajorHealth Technology Arandi Development AB is a Swedish pharmaceutical manufacturing company. The private company is based in Stockholm, Sweden. | Corporate Officer/Principal | - | - |
Historique de carrière de Pirkko Sulila Tamsen
Anciens postes connus de Pirkko Sulila Tamsen
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONCOZENGE AB | Directeur Général | 01/09/2020 | 01/11/2021 |
Directeur des opérations | 01/11/2021 | 01/09/2023 | |
Rapp AB
![]() Rapp AB Information Technology ServicesTechnology Services Rapp AB is a healthcare company based in Örebro, Sweden that provides a systematic approach to postoperative care and quality control. Rapp's innovation, developed by Professor Ulrica Nilsson, involves the use of a patient questionnaire to track their recovery progress and provide quality data to healthcare providers. The goal is to increase patient participation, knowledge, and security while reducing the need for unplanned contacts with healthcare providers. Rapp has won the World Innovation Summit for Health award in 2021. The Swedish company was founded in 2015 by Björn Pettersson and Ulrica Nilsson, with Anders Harald Thunberg as the current CEO. | Directeur/Membre du Conseil | 01/05/2018 | 01/10/2018 |
Karolinska Institutet Innovations AB
![]() Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | 01/04/2014 | 01/03/2017 |
░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Pirkko Sulila Tamsen
University of Uppsala | Doctorate Degree |
Statistiques
Internationale
Suède | 23 |
Danemark | 2 |
Opérationnelle
Director/Board Member | 10 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 4 |
Sectorielle
Health Technology | 9 |
Commercial Services | 4 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALZECURE PHARMA AB | Health Technology |
ONCOZENGE AB | Health Technology |
Entreprise privées | 20 |
---|---|
NovaSAID AB
![]() NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Health Technology |
SEDOC Pharmaceutical Medicine AB | Health Technology |
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Kabi Pharmacia | |
A+ Science AB
![]() A+ Science AB Miscellaneous Commercial ServicesCommercial Services A+ Science AB plans and conducts clinical trials for pharmaceutical and medical device companies. It offers outsourced research services to pharmaceutical companies. The company was founded in 1997 and is headquartered in Stockholm, Sweden. | Commercial Services |
Karolinska Institutet Innovations AB
![]() Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
Orebro Universitet Holding AB
![]() Orebro Universitet Holding AB Miscellaneous Commercial ServicesCommercial Services Orebro Universitet Holding AB provides scientific, technical research and development services. The private company is based in Örebro, Sweden. | Commercial Services |
Modus Therapeutics AB
![]() Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
Arandi Innovation AB | |
Curenc AB
![]() Curenc AB BiotechnologyHealth Technology Curenc AB engages in the research and development of pharmaceutical products. It develops a peptide that kills various types of bacteria including multi-resistant staphylococcus. The company is headquartered in Sweden. | Health Technology |
Oerebro Universitet Uppdrag AB | |
Oerebro Universitet Enterprise AB
![]() Oerebro Universitet Enterprise AB Miscellaneous Commercial ServicesCommercial Services Oerebro Universitet Enterprise AB is a Swedish company that engages in other scientific and technical research & development. The private company is based in Örebro, Sweden. | Commercial Services |
Hepapredict AB | |
C26 Bioscience AB | |
Arandi Development AB
![]() Arandi Development AB Pharmaceuticals: MajorHealth Technology Arandi Development AB is a Swedish pharmaceutical manufacturing company. The private company is based in Stockholm, Sweden. | Health Technology |
Rapp AB
![]() Rapp AB Information Technology ServicesTechnology Services Rapp AB is a healthcare company based in Örebro, Sweden that provides a systematic approach to postoperative care and quality control. Rapp's innovation, developed by Professor Ulrica Nilsson, involves the use of a patient questionnaire to track their recovery progress and provide quality data to healthcare providers. The goal is to increase patient participation, knowledge, and security while reducing the need for unplanned contacts with healthcare providers. Rapp has won the World Innovation Summit for Health award in 2021. The Swedish company was founded in 2015 by Björn Pettersson and Ulrica Nilsson, with Anders Harald Thunberg as the current CEO. | Technology Services |
Uppsala Universitet Innovation Tools AB | |
Arandi Holdings AB | |
Uppsala Berzelii Technology Centre For Neurodiagnostics | |
Uppsala University Innovation |
- Bourse
- Insiders
- Pirkko Sulila Tamsen
- Expérience